health risks of glp 1 GLP-1 medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1-slash-risk -4-types-cancer-50-or-more-study The Benefits of GLP-1 Therapy:

Recently, another selective inhibitor of GLS1, CB-839 (telaglenastat), showed no significant side effects in preclinical trials and is currently undergoing full clinical trials 45

The product is being marketed through a partnership between Eli Lilly's Japanese subsidiary and Mitsubishi Tanabe Pharma, establishing a strengthened system for domestic sales and distribution

Sci Rep, 2015

Reilly, R

reported that while PDT on human and mouse melanoma cells using various procedures significantly increased apoptosis, necrosis, tumor growth halt, and prolonged animal life in experimental settings, it rarely resulted in full recovery and/or was accompanied by recurrence and side effects